Evidence Based Pharmacotherapy of Pediatric Traumatic Brain Injury

Published by Pediatric Pharmacy Association


Traumatic brain injuries are unfortunately common in the pediatric population and result in significant morbidity and mortality. There are, however, a number of pharmacotherapy interventions which improve outcomes in the brain injured child. In this presentation, we will use the case of an injured child to explore some key pathophysiology which impacts medication therapy, describe effective employment of hyperosmolar and sedative therapies and consider some adjunctive medications which may be useful in these patients.

Learning Objectives for Pharmacists:
At the end of this session, participants will be able to:
1. Explain how the pathophysiology of traumatic brain injury impacts pharmacotherapy.
2. Employ intracranial pressure monitoring to guide pharmacotherapy of traumatic brain injury.
3. Make evidence-based recommendations for hyperosmolar therapy of traumatic brain injury.
4. Design analgesic, sedative and neuromuscular blockade therapy for the traumatic brain injury patient.
5. Recommend adjunctive medication therapy in traumatic brain injury

ACPE logo PPAG has accredited this knowledge-based webinar for 1.0 contact hours (0.10 CEUs) of continuing education credit for pharmacists. UAN #:0180-0000-20-006-H01-P.

The Pediatric Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. In order to receive credit, participants must register for the program, attend the program, and fill out a post-program survey. Webinar programs are 100% supported through program registration fees and PPA membership dues, and is not supported by Industry.

Group Pricing for CE only:
Groups will need to email Lauren Henretty at lhenretty@pediatricpharmacy.org their attendance list with each participants name, email, NABP# and DOB in order to receive credit.

Franklin Huggins, Pharm.D., BCPPS, BCCCP
Associate Professor - West Virginia University School of Pharmacy
Franklin Huggins is Associate Professor of Clinical Pharmacy at West Virginia University and Pediatric Clinical Pharmacy Specialist for CAMC Women and Children’s Hospital in Charleston, West Virginia where he provides clinical pharmacy services in the pediatric ICU. He is a graduate of North Carolina State University and earned his Doctor of Pharmacy from the University of Utah. Dr. Huggins is board certified in critical care and pediatric pharmacotherapy.

Originally Published

June 10, 2020

Program Titles and Supporting Materials

This program contains the following components:

  • Evidence Based Pharmacotherapy of Pediatric Traumatic Brain Injury - Video
  • Evidence Based Pharmacotherapy of Pediatric Traumatic Brain Injury - Paper

How To Attend

Join the self-paced program from your office, home, or hotel room using a computer and high speed internet connection. You may start and stop the program at your convenience, continue where you left off, and review supporting materials as often as you like. Please note: Internet Explorer is no longer a supported browser. We recommend using Google Chrome, Mozilla Firefox or Safari for best results.

Technical Requirements

You may access this course on a computer or mobile device with high speed internet (iPhones require iOS 10 or higher). Recommended browsers are Google Chrome or Mozilla Firefox.


If applicable, you may obtain credit in multiple jurisdictions simultaneously for this program (see pending/approved list below). If electing credit for this program, registrants in jurisdictions not listed below will receive a Certificate of Completion that may or may not meet credit requirements in other jurisdictions. Where applicable, credit will be only awarded to a paid registrant completing all the requirements of the program as determined by the selected accreditation authority.

Click on jurisdiction for specific details

You May Also Be Interested In...
On-Demand Programs

There’s More Than Just CBD: Updates in the Management of Seizures in Children (Credit: ACPE (Pharmacists))
Published on 11/13/2019

Management of Loperamide Toxicity and Cannabinoid Hyperemesis Syndrome in Pediatric Patients (Credit: ACPE (Pharmacists))
Published on 10/30/2019

Need Some Insulin? K! Managing Pediatric DKA (Credit: ACPE (Pharmacists))
Published on 9/4/2019

The Wheezy Truth: the do’s and don’ts to managing acute pediatric asthma in the ED (Credit: ACPE (Pharmacists))
Published on 8/7/2019

Being Competent on Competencies: Strategies for Pediatric Hospitals (Credit: ACPE (Pharmacists))
Published on 7/24/2019

Autism Spectrum Disorder: What to Expect from Medication Trials (Credit: ACPE (Pharmacists))
Published on 6/12/2019

New Tools and Concepts for Antibiotic Stewardship (Credit: ACPE (Pharmacists))
Published on 4/3/2019

SMOF, Omegaven, or Intralipid - Which one for PNALD, BPD, ROP (Credit: ACPE (Pharmacists))
Published on 1/23/2019

Pediatric Heart Failure Management: How Hard Can It Be?
Published on 9/13/2017

New Therapies & Controversies in Chronic Kidney Disease Management
Published on 5/24/2017

Refund Policy

SeminarWeb and Pediatric Pharmacy Association programs are non-refundable.

Privacy Statement

We respect and are committed to protecting your privacy. (Read Statement)

Tell a Colleague!


For immediate assistance please consult our FAQ page.

If you're unable to find the answer you need, please call 737-201-2059 (M-F, 8am-6pm CT) or e-mail customer service.

Powered by

Powered by SeminarWeb.com